< 1 minute read
Sep. 17, 2021

BAY1161909: A Pro-Mitotic Selective MPS1 Kinase Inhibitor

BAY1161909

pro-mitotic selective MPS1 kinase inhibitor dev. paused for 2nd candidate (BAY1217389) from 2M cmpd biochem. HTS and SBDD J. Med. Chem., Apr. 27, 2020 Bayer AG, Berlin, DE

twitterlinkedinprintemail